{"schema_version":"secwatch.filing_event.v1","accession":"0001021771-24-000158","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.288248+00:00","generated_at":"2026-05-31T12:14:21.657992+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"BioRestorative Therapies schedules Q2 2024 earnings release and call for Aug 13","bullets":["Financial results for Q2 2024 will be released after market close on Tuesday, August 13, 2024.","Management will host a conference call following the release to review results and provide a business update.","Press release announcing the schedule was issued on August 6, 2024.","No financial figures or guidance were provided in this filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001021771-24-000158","json":"https://secwatch.observer/filing/0001021771-24-000158.json","markdown":"https://secwatch.observer/filing/0001021771-24-000158.md","text":"https://secwatch.observer/filing/0001021771-24-000158.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000158/0001021771-24-000158-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000158/brt8624.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:14:21.657992+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}